GB2095 is an orally active and selective galectin-3 inhibitor. GB2095 shows superior selectivity for both human (KD = 0.036 µM) and mouse galectin-3 (KD = 0.35 µM) over other galectins (such as h-Gal-1/4N/4C/8N/8C/9N/9C and m-galectin-1). GB2095 inhibits tumor growth in syngeneic mouse models of breast and melanoma cancers. GB2095 can be used for breast and melanoma cancer research[1].
Molecular Weight:
548.79
Purity:
98.92
CAS Number:
[2574415-75-9]
Formula:
C20H17BrClF2N3O4S
Target:
Galectin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
